Serum endostatin is selectively reduced in non-steatotic chronic hepatitis C and normalizes after direct-acting antiviral therapy: a prospective cohort study.

Weigand K, Peschel G, Müller M, Buechler C

DOI: 10.1186/s12876-026-05500-2
Published: 2026 Nov 6
Container: BMC gastroenterology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12876-026-05500-2,
  title = {Serum endostatin is selectively reduced in non-steatotic chronic hepatitis C and normalizes after direct-acting antiviral therapy: a prospective cohort study.},
  author = {Weigand K and Peschel G and Müller M and Buechler C},
  year = {2026},
  journal = {BMC gastroenterology},
  doi = {10.1186/s12876-026-05500-2},
  url = {https://doi.org/10.1186/s12876-026-05500-2}
}

RIS

TY  - JOUR
TI  - Serum endostatin is selectively reduced in non-steatotic chronic hepatitis C and normalizes after direct-acting antiviral therapy: a prospective cohort study.
AU  - Weigand K
AU  - Peschel G
AU  - Müller M
AU  - Buechler C
PY  - 2026
JO  - BMC gastroenterology
DO  - 10.1186/s12876-026-05500-2
UR  - https://doi.org/10.1186/s12876-026-05500-2
ER  -

APA

K, W., G, P., M, M., & C, B. (2026). Serum endostatin is selectively reduced in non-steatotic chronic hepatitis C and normalizes after direct-acting antiviral therapy: a prospective cohort study.. BMC gastroenterology. https://doi.org/10.1186/s12876-026-05500-2

Source records

pubmed · retrieved 2026-11-10T10:58:13.242Z